ATE554763T1 - Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation - Google Patents
Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisationInfo
- Publication number
- ATE554763T1 ATE554763T1 AT02703362T AT02703362T ATE554763T1 AT E554763 T1 ATE554763 T1 AT E554763T1 AT 02703362 T AT02703362 T AT 02703362T AT 02703362 T AT02703362 T AT 02703362T AT E554763 T1 ATE554763 T1 AT E554763T1
- Authority
- AT
- Austria
- Prior art keywords
- age
- occult
- macular degeneration
- related macular
- chorioidal
- Prior art date
Links
- 206010064930 age-related macular degeneration Diseases 0.000 title abstract 2
- 208000002780 macular degeneration Diseases 0.000 title abstract 2
- 238000002428 photodynamic therapy Methods 0.000 title abstract 2
- 206010029113 Neovascularisation Diseases 0.000 title 1
- 230000003902 lesion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26694001P | 2001-02-06 | 2001-02-06 | |
| PCT/US2002/003758 WO2002062386A2 (en) | 2001-02-06 | 2002-02-06 | Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554763T1 true ATE554763T1 (de) | 2012-05-15 |
Family
ID=23016614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02703362T ATE554763T1 (de) | 2001-02-06 | 2002-02-06 | Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8034803B2 (de) |
| EP (1) | EP1357912B9 (de) |
| AT (1) | ATE554763T1 (de) |
| AU (1) | AU2002236988A1 (de) |
| CA (1) | CA2437563C (de) |
| ES (1) | ES2386718T3 (de) |
| WO (1) | WO2002062386A2 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE364398T1 (de) * | 2001-01-30 | 2007-07-15 | Altachem Pharma Ltd | Perylenequinone zur anwendung mit immunotherapeutischen mitteln |
| PT1357946E (pt) | 2001-02-06 | 2008-06-27 | Quadra Logic Tech Inc | Terapia fotodinâmica com taxa de fluência reduzida |
| US7060695B2 (en) | 2001-02-06 | 2006-06-13 | Qlt, Inc. | Method to prevent vision loss |
| US7753943B2 (en) | 2001-02-06 | 2010-07-13 | Qlt Inc. | Reduced fluence rate PDT |
| US7303578B2 (en) * | 2001-11-01 | 2007-12-04 | Photothera, Inc. | Device and method for providing phototherapy to the brain |
| US20050159793A1 (en) * | 2002-07-02 | 2005-07-21 | Jackson Streeter | Methods for treating macular degeneration |
| WO2004034889A2 (en) * | 2002-10-18 | 2004-04-29 | The Regents Of The University Of California | Photodynamic therapy for ocular neovascularization |
| US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| ATE442861T1 (de) * | 2003-03-07 | 2009-10-15 | Univ Texas | Gegen antikörper gerichtete photodynamische therapie |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| EP1824496A4 (de) * | 2004-11-17 | 2008-07-16 | Joanne Mclaurin | Zusammensetzungen aus scyllo-inositol-derivaten und verfahren zur behandlung von störungen der proteinaggregation |
| AU2006279189B2 (en) | 2005-08-10 | 2011-08-04 | Quest Pharmatech Inc. | Perylenequinone derivatives and uses thereof |
| JP2009511568A (ja) * | 2005-10-13 | 2009-03-19 | ワラタ ファーマシューティカルズ， インコーポレイテッド | イノシトール誘導体、ならびに異常なタンパク質の折りたたみまたは凝集、あるいはアミロイドの形成、沈着、蓄積または残存を特徴とする疾患の処置におけるその使用 |
| US20070197452A1 (en) * | 2006-02-17 | 2007-08-23 | Mclaurin Joanne | Treatment of amyloid-related diseases |
| WO2007129221A2 (en) * | 2006-02-17 | 2007-11-15 | Waratah Parmaceuticals Inc | Compositions comprising an epi-inositol compounds and methods for treatment of disorders of protein aggregation |
| KR20090026247A (ko) * | 2006-03-09 | 2009-03-12 | 와라타 파마수티컬즈, 인크. | 단백질 응집 장애의 치료를 위한 사이클로헥산 폴리알콜 제형 |
| CA2652449A1 (en) * | 2006-05-19 | 2007-11-29 | Waratah Pharmaceuticals Inc. | Screening methods for amyloid beta modulators |
| US8454991B2 (en) | 2006-07-24 | 2013-06-04 | Quest Pharmatech Inc. | Method and device for photodynamic therapy |
| WO2008034244A1 (en) * | 2006-09-21 | 2008-03-27 | Waratah Pharmaceuticals Inc. | The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases |
| EP2091566A4 (de) * | 2006-11-24 | 2011-07-06 | Waratah Pharmaceuticals Inc | Kombinationstherapien gegen alzheimer-krankheit und ähnliche erkrankungen |
| RU2333022C1 (ru) * | 2007-03-05 | 2008-09-10 | Федеральное Государственное Учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" | Способ фотодинамической терапии хориоидальных неоваскулярных мембран |
| CA2683580A1 (en) * | 2007-04-12 | 2008-10-23 | Joanne Mclaurin | Treatment of amyotrophic lateral sclerosis |
| WO2008124929A1 (en) * | 2007-04-12 | 2008-10-23 | Joanne Mclaurin | USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF α-SYNUCLEINOPATHIES |
| WO2008124930A1 (en) * | 2007-04-12 | 2008-10-23 | Joanne Mclaurin | Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases |
| HRP20130768T1 (en) * | 2007-04-12 | 2013-10-25 | Waratah Pharmaceuticals, Inc. | Use of cyclohexanehexol derivatives in the treatment of ocular diseases |
| WO2010040232A1 (en) * | 2008-10-09 | 2010-04-15 | Waratah Pharmaceuticals Inc. | Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| US8829020B2 (en) | 2009-07-16 | 2014-09-09 | Mallinckrodt Llc | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| TWI702955B (zh) * | 2012-05-15 | 2020-09-01 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒（ａａｖ）ｓｆｌｔ-１治療老年性黃斑部退化（ａｍｄ） |
| ES3042252T3 (en) | 2014-03-17 | 2025-11-19 | Adverum Biotechnologies Inc | Compositions and methods for enhanced gene expression in cone cells |
| SI3230316T1 (sl) * | 2014-12-11 | 2022-05-31 | Bayer Healthcare Llc | Zdravljenje starostne degeneracije makule z majhno aktivno horoidalno neovaskularizacijsko lezijo |
| CN114480502A (zh) | 2015-03-02 | 2022-05-13 | 阿德夫拉姆生物技术股份有限公司 | 用于将多核苷酸玻璃体内递送到视网膜视锥的组合物和方法 |
| GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
| US11519020B2 (en) | 2018-05-25 | 2022-12-06 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798349A (en) * | 1994-03-14 | 1998-08-25 | The General Hospital Corporation | Use of green porphyrins to treat neovasculature in the eye |
| US5935942A (en) * | 1994-12-14 | 1999-08-10 | Zeimer; Ran | Selective and non-invasive visualization or treatment of vasculature |
-
2002
- 2002-02-06 EP EP02703362A patent/EP1357912B9/de not_active Expired - Lifetime
- 2002-02-06 WO PCT/US2002/003758 patent/WO2002062386A2/en not_active Ceased
- 2002-02-06 AU AU2002236988A patent/AU2002236988A1/en not_active Abandoned
- 2002-02-06 US US10/072,272 patent/US8034803B2/en not_active Expired - Lifetime
- 2002-02-06 AT AT02703362T patent/ATE554763T1/de active
- 2002-02-06 CA CA2437563A patent/CA2437563C/en not_active Expired - Lifetime
- 2002-02-06 ES ES02703362T patent/ES2386718T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20030087889A1 (en) | 2003-05-08 |
| WO2002062386A2 (en) | 2002-08-15 |
| WO2002062386A3 (en) | 2002-10-24 |
| CA2437563C (en) | 2010-03-23 |
| US8034803B2 (en) | 2011-10-11 |
| EP1357912B1 (de) | 2012-04-25 |
| EP1357912B9 (de) | 2012-06-13 |
| EP1357912A2 (de) | 2003-11-05 |
| ES2386718T3 (es) | 2012-08-28 |
| CA2437563A1 (en) | 2002-08-15 |
| AU2002236988A1 (en) | 2002-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE554763T1 (de) | Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation | |
| AR037307A1 (es) | Metodos para el tratamiento de enfermedades oculares neovasculares | |
| TNSN05300A1 (en) | Treatment with anti-vegf antibodies | |
| WO2002096366A3 (en) | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy | |
| DK1558616T3 (da) | Meso-substituerede porphyriner | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| CY1110721T1 (el) | Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις | |
| LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| CY1106816T1 (el) | 1,5-δισυποκαταστημενες ενωσεις 3,4-διυδρο-1h-πυριμιδο [4,5-d] πυριμιδιν-2-ονης και η χρησιμοποιηση αυτων δια τη θεραπευτικη αγωγη ασθενειων εις τις οποιες μεσολαβει η csbp/p38 κιναση | |
| AU4550801A (en) | Herbal composition phy906 and its use in chemotheraphy | |
| WO2002058730A3 (en) | Compositions for treatment of ocular neovascularization | |
| CY1111999T1 (el) | Λακτοφερρινη στην αγωγη κακοηθων νεοπλασματων και αλλων υπερπλαστικων νοσων | |
| TR200402628T4 (tr) | Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı | |
| CY1108983T1 (el) | Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων | |
| EP1605847A4 (de) | Gegen antikörper gerichtete photodynamische therapie | |
| NO20024486D0 (no) | Forbedret behandling av neovaskularisering | |
| BRPI0407693A (pt) | uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos | |
| WO2003028629A3 (en) | Chlorin photosensitizing agents for use in photodynamic therapy | |
| TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
| NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
| MXPA04007443A (es) | Nuevos compuestos de porfirina-platino solubles en agua con alta selectividad tumoral y su uso para el tratamiento de enfermedades tumorales benignas y malignas. | |
| WO2003028628A3 (en) | Photosensitizing carbamate derivatives | |
| WO2003032902A3 (en) | Tumor targeted photodiagnostic-phototherapeutic agents | |
| AU2002234644A1 (en) | Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases | |
| ATE344054T1 (de) | Behandlung von okularen neovaskularen erkrankungen |